位置:首页 > 产品库 > AG-636
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
AG-636
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
AG-636图片
CAS NO:1623416-31-8
包装与价格:
包装价格(元)
10mM (in 1mL DMSO)询价
5mg询价
10mg询价
25mg询价
50mg询价
100mg询价

AG-636 是一种有效,可逆,选择性和具有口服活性的二氢乳清酸脱氢酶 (DHODH) 抑制剂,IC50 为 17 nM。AG-636 具有很强的抗癌作用。
Cas No.1623416-31-8
分子式C21H17N3O2
分子量343.38
溶解度DMSO : 31.25 mg/mL (91.01 mM; Need ultrasonic)
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

AG-636 is a potent, reversible, selective and orally active dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 of 17 nM. AG-636 has strong anticancer effects[1].

AG-636 has strong growth-inhibitory activity in cancer cell lines of hematologic versus solid tumor origin[1].

AG-636 (10-100 mg/kg ; oral gavage; twice daily; for 14 days) treatment results in robust tumor growth inhibition in the OCILY19 DLBCL tumor xenograft model[1].

[1]. Gabrielle McDonald, et al. Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase. Mol Cancer Ther. 2020 Dec;19(12):2502-2515.

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024